Zimmer Biomet Holdings (ZBH) Accumulated Expenses (2010 - 2026)

Zimmer Biomet Holdings has reported Accumulated Expenses for 17 years, with the latest figure at $293.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses changed N/A year-over-year to $293.9 million; the trailing twelve-month figure through Mar 2026 stood at $293.9 million (changed N/A YoY), and the FY2025 full-year result was $477.1 million, down 32.47% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $293.9 million, down from $477.1 million in the prior quarter.
• The five-year high for Accumulated Expenses was $706.5 million in Q4 2024, with the low at $184.5 million in Q1 2022.
• Average Accumulated Expenses over 5 years is $360.3 million, with a median of $315.0 million recorded in 2022.
• Year-over-year, Accumulated Expenses plunged 37.3% in 2022 and soared 69.38% in 2024.
• Tracing ZBH's Accumulated Expenses over 5 years: stood at $336.2 million in 2022, then grew by 24.06% to $417.1 million in 2023, then soared by 69.38% to $706.5 million in 2024, then sank by 32.47% to $477.1 million in 2025, then slumped by 38.4% to $293.9 million in 2026.
• The last three Accumulated Expenses figures came in at $293.9 million (Q1 2026), $477.1 million (Q4 2025), and $706.5 million (Q4 2024), per Business Quant data.

Peer Comparison